Friday 10 April |
no events scheduled |
Monday 13 April |
no events scheduled |
Tuesday 14 April |
ValiRX (re removal of directors) |
Big Sofa Technologies Group (cancelling admission of shares) |
Wednesday 15 April |
Hunting |
Diversified Gas & Oil |
Bunzl |
Thursday 16 April |
Verona Pharma |
China New Energy |
African Oil & Gas |
Global Ports Holdings |
Simigon |
Copyright 2020 Alliance News Limited. All Rights Reserved. |
Verona Pharma shares surge after results from latest study
(Sharecast News) - Respiratory disease-focussed biopharmaceuticals company Verona Pharma announced positive top-line data from a four week, 416 patient phase 2b dose-ranging study evaluating nebulised ensifentrine or placebo as an add-on treatment to 'Spiriva Respimat', or tiotropium, which is a long acting anti-muscarinic bronchodilator, in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).
Read more